½ÃÀ庸°í¼­
»óǰÄÚµå
1606265

¼¼°èÀÇ ¹ÙÀÌ¿À¸ÞµðÄÃ¿ë ¼Ò À¯·¡ Äݶó°Õ ½ÃÀå : À¯Çü, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº°¿¹Ãø(2025-2030³â)

Bovine-Based Collagen for Biomedical Applications Market by Type (Type I, Type III), Application (Bone Graft Substitutes, Cartilage Repairs, Collagen-based Scaffolds), End-user - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 189 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¹ÙÀÌ¿À¸ÞµðÄÃ¿ë ¼Ò À¯·¡ Äݶó°Õ ½ÃÀåÀº 2023³â¿¡ 13¾ï 7,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 14¾ï 7,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 9.72%·Î ¼ºÀåÇÏ¿©, 2030³â¿¡´Â 26¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼Ò À¯·¡ Äݶó°ÕÀº »ýºÐÇØ¼º°ú »ýüÀûÇÕ¼ºÀÇ Æ¯¼º¿¡ ÀÇÇØ ¹ÙÀÌ¿À¸ÞµðÄà ºÐ¾ß¿¡¼­ÀÇ Á߿伺ÀÌ ³ô¾ÆÁö°í ÀÖ¾î »óóġ·á, Á¶Á÷°øÇÐ, Àç»ýÀÇ·á µîÀÇ ¿ëµµ¿¡ ÀÌ»óÀûÀÔ´Ï´Ù. ¼¼°èÀÇ °ü½ÉÀº ÇØ»ê ÄÚ¶ó - °Õ°ú µÅÁö Äݶó°Õ°ú °°Àº ´ëüǰ¿¡ ºñÇØ ºñ¿ë È¿°ú°¡ ³ô°í ÀÔ¼öÇϱ⠽¬¿î °ÍÀÌ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÎü Á¶Á÷À» ´ëüÇÏ°í ¼ö¸®Çϰí Ä¡·á È¿°ú¸¦ ³ôÀÏ Çʿ伺ÀÌ Áõ°¡Çϰí Àֱ⠶§¹®¿¡ ÃÖÁ¾ ¿ëµµ¿¡´Â Á¶Á÷°øÇÐ¿ë ¹ßÆÇ, ¾à¹°Àü´Þ ½Ã½ºÅÛ, Çõ½ÅÀûÀÎ »óó ÇǺ¹Àç µîÀÌ Æ÷ÇԵ˴ϴÙ. ºñÀ² »ó½Â, °í±Þ ÀÇ·á ÇÊ¿ä °í·ÉÈ­, Ä¡·á¿¡¼­ Äݶó°ÕÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡¿¡ Å©°Ô ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. Â÷¼¼´ë Äݶó°Õ Á¦Ç°ÀÇ °³¹ßÀ» À§ÇÑ ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ, »ý¹°ÀÇÇבּ¸±â°ü°úÀÇ Çù·Â°ü°èÀÇ ¸ð»ö, Çõ½ÅÀÇ ¿©Áö°¡ Å« °áÇÕÁ¶Á÷°øÇп¡ À־ÀÇ ¾Ï¸ä, ´ÏÁî¿¡ÀÇ ´ëÀÀÀ» ÃßõÇϰí ÀÖ½À´Ï´Ù. À±¸®Àû ¿ì·Á, ±ÔÁ¦ Àå¾Ö¹°, µ¿¹° À¯·¡ Äݶó°Õ°ú °ü·ÃµÈ ÀáÀçÀû Áúº´ º¯¼ÓÀÇ À§Çè µî ¿©·¯ ¹®Á¦°¡ ¼ºÀåÀ» ¹æÇØÇϰí ÀÖ½À´Ï´Ù. ±â¾÷Àº ÀÌ·¯ÇÑ À庮À» ±Øº¹Çϱâ À§ÇØ ¾ö°ÝÇÑ ¾ÈÀü ±âÁذú À±¸®Àû ¿ì¸®´Â Á¶´ÞÀ» º¸ÀåÇØ¾ßÇÕ´Ï´Ù. ½ÃÀå °æÀïÀº Áß°£ Á¤µµÀ̸ç ÁÖ¿ä ±â¾÷Àº Á¦Ç° Æ÷Æ®Æú¸®¿ÀÀÇ È®´ë¿Í ±â¼ú Çõ½ÅÀ» ÅëÇÑ Á¦Ç° ǰÁú Çâ»ó¿¡ ÁßÁ¡À» µÓ´Ï´Ù. ÇÔ²² Á¶Á¤ °³º°È­ µÈ ÀÇ·á¿Í °°Àº Æ´»õ ºÐ¾ß¿¡ ºñÁî´Ï½º ±âȸ°¡ Á¸ÀçÇÕ´Ï´Ù. Àü¹ÝÀûÀ¸·Î ½ÃÀåÀº Áö¼ÓÀûÀÎ ÁøÈ­¿Í ºñÁî´Ï½º ¼ºÀåÀÇ ¿©Áö°¡ Á¦Ç° ¿ëµµÀÇ Áö¼ÓÀûÀÎ Çõ½Å°ú ±ÔÁ¦ Áؼö¸¦ °³¼±ÇÔÀ¸·Î½á ¹ø¿µÇϰí ÀÖ½À´Ï´Ù. ÀÖ´Ù´Â °ÍÀ» ¾Ï½ÃÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 13¾ï 7,000¸¸ ´Þ·¯
ÃßÁ¤³â(2024) 14¾ï 7,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 26¾ï 3,000¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 9.72%

½ÃÀå ¿ªÇÐ : ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â ¹ÙÀÌ¿À¸ÞµðÄÃ¿ë ¼Ò À¯·¡ Äݶó°Õ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¹ÙÀÌ¿À¸ÞµðÄÃ¿ë ¼Ò À¯·¡ Äݶó°Õ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. Àû ÀÇ»ç °áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ¿ÏÈ­ÇÒ ¼ö ÀÖÀ¸¸ç, ¶ÇÇÑ ¼ÒºñÀÚ Çൿ ±×¸®°í ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¼¼°èÀÇ °í·ÉÈ­ÀÇ ÁøÀü°ú »À °ü·Ã Áúȯ Áõ°¡
    • ¹ÙÀÌ¿À¸ÞµðÄà ½ÅÈï±â¾÷ ÅõÀÚ Áõ°¡·Î Á¦Ç°Á¦°ø È®´ë
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • º¹ÀâÇÏ°í ¾ôÈù Á¦Á¶ °øÁ¤¿¡ µû¸¥ °í ºñ¿ë
  • ½ÃÀå ±âȸ
    • Ä¡°ú ¹× Á¤Çü¿Ü°ú ¼ö¼ú ¼ö¿ä Áõ°¡
    • »óó Ä¡À¯, Àç»ý ÀÇ·á °³¹ßÀ» À§ÇÑ Áö¼ÓÀûÀÎ ¿¬±¸ °³¹ß
  • ½ÃÀåÀÇ °úÁ¦
    • Áúº´ º¯¼Ó±âÀÇ ³ôÀº À§Çè

Porter's Five Forces : ¹ÙÀÌ¿À¸ÞµðÄÃ¿ë ¼Ò À¯·¡ Äݶó°Õ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÆÄ¾ÇÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» ÇØ°áÇϰí ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÔÀ¸·Î½á º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¹ÙÀÌ¿À¸ÞµðÄÃ¿ë ¼Ò À¯·¡ Äݶó°Õ ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¹ÙÀÌ¿À¸ÞµðÄÃ¿ë ¼Ò À¯·¡ Äݶó°Õ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ °¡´ÉÇÕ´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ¹ÙÀÌ¿À¸ÞµðÄÃ¿ë ¼Ò À¯·¡ Äݶó°Õ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

»ý¹° ÀÇÇÐ ¿ëµµ¿¡ ´ëÇÑ ¼Ò À¯·¡ Äݶó°Õ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ º¥´õÀÇ ½ÇÀûÀ» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ¹ÙÀÌ¿À¸ÞµðÄÃ¿ë ¼Ò À¯·¡ Äݶó°Õ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Positioning Matrix´Â »ý¹° ÀÇÇÐ ÀÀ¿ëÀ» À§ÇÑ ¾Ï¼Ò À¯·¡ Äݶó°Õ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡Çϱâ À§ÇÑ Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå »ý¹° ÀÇÇÐ ¿ëµµ¸¦À§ÇÑ ¾Ï¼Ò À¯·¡ Äݶó°Õ ½ÃÀåÀÇ ¼º°ø¿¡ ´ëÇÑ ±æÀ» ±×¸³´Ï´Ù.

»ý¹° ÀÇÇÐ ¿ëµµ¸¦ À§ÇÑ ¾Ï¼Ò À¯·¡ Äݶó°Õ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖ´Â ½Ã½ºÅÛÀ» ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¼¼°è¿¡¼­ Àα¸ÀÇ °í·ÉÈ­°¡ ÁøÇàµÇ°í, »À °ü·Ã ÁúȯÀÇ ÀÌȯÀ²ÀÌ »ó½ÂÇϰí ÀÖ´Ù
      • ¹ÙÀÌ¿À¸ÞµðÄÃÀÇ ½ÅÈï±â¾÷¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡, ¼­ºñ½º È®´ë¿¡
    • ¾ïÁ¦¿äÀÎ
      • º¹ÀâÇÏ°í º¹ÀâÇÑ »ý»ê °øÁ¤°ú °ü·ÃµÈ ³ôÀº ºñ¿ë
    • ±âȸ
      • Ä¡°ú ¹× Á¤Çü¿Ü°ú ¼ö¼ú ¼ö¿ä Áõ°¡
      • »óó Ä¡À¯ ¹× Àç»ý ÀÇ·áÀÇ °³¹ßÀ» ÇâÇÑ Áö¼ÓÀûÀÎ ¿¬±¸ °³¹ß
    • °úÁ¦
      • Áúº´ÀÇ º¯¼Ó À§ÇèÀÌ ³ô´Ù
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ¹ÙÀÌ¿À¸ÞµðÄÃ¿ë ¼Ò À¯·¡ Äݶó°Õ ½ÃÀå : À¯Çüº°

  • À¯Çü I
  • À¯Çü III

Á¦7Àå ¹ÙÀÌ¿À¸ÞµðÄÃ¿ë ¼Ò À¯·¡ Äݶó°Õ ½ÃÀå : ¿ëµµº°

  • »À ÀÌ½Ä ´ëüǰ
  • ¿¬°ñ º¹±¸
  • Äݶó°Õ ±â¹Ý ºñ°è
  • ÁöÇ÷Á¦
  • ÇǺΠ´ëüǰ
  • »óó ÇǺ¹Àç

Á¦8Àå ¹ÙÀÌ¿À¸ÞµðÄÃ¿ë ¼Ò À¯·¡ Äݶó°Õ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • º´¿ø

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ¹ÙÀÌ¿À¸ÞµðÄÃ¿ë ¼Ò À¯·¡ Äݶó°Õ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¹ÙÀÌ¿À¸ÞµðÄÃ¿ë ¼Ò À¯·¡ Äݶó°Õ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¹ÙÀÌ¿À¸ÞµðÄÃ¿ë ¼Ò À¯·¡ Äݶó°Õ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Advanced BioMatrix Inc.
  • BBI Solutions
  • Botiss biomaterials GmbH
  • Bovine Collagen Products
  • Collagen Matrix, Inc.
  • Collagen Solutions PLC
  • Crescent Biotech
  • Darling Ingredients
  • Eucare Pharmaceuticals Private Limited
  • Fisher Scientific International, Inc.
  • Gelita AG
  • Getinge AB
  • Integra LifeSciences Holdings Corporation
  • InterHealth Nutraceuticals Inc.
  • Lapi Gelatine SpA
  • Medtronic PLC
  • Nippi,incorporated
  • Nitta Gelatin, Inc.
  • NuCollagen LLC
  • Shenzhen Ruifuer Electronic Co. Ltd.
  • Symatese
  • Tessenderlo Group
  • Titan Biotech Ltd.
  • Viscofan DE GmbH
  • Weishardt International
BJH 24.12.16

The Bovine-Based Collagen for Biomedical Applications Market was valued at USD 1.37 billion in 2023, expected to reach USD 1.47 billion in 2024, and is projected to grow at a CAGR of 9.72%, to USD 2.63 billion by 2030.

Bovine-based collagen is increasingly important in the biomedical sector due to its biodegradable and biocompatible properties, making it ideal for applications like wound care, tissue engineering, and regenerative medicine. The global interest in bovine collagen is driven by its cost-effectiveness and high availability compared to alternatives like marine or porcine collagen. The necessity arises from the growing need for biologically safe and effective biomaterials to replace or repair damaged human tissues and enhance therapeutic outcomes. End-use scope includes its application in creating scaffolds for tissue engineering, drug delivery systems, and innovative wound dressings. Market growth is heavily influenced by the rising prevalence of chronic diseases, an aging population needing advanced medical care, and increasing awareness about the benefits of collagen in medical treatments. Additionally, technological advancements in collagen modification and processing methods present lucrative opportunities for expansion. Companies are recommended to invest in R&D for developing next-generation collagen products, exploring collaborations with biomedical research institutions, and addressing unmet needs in connate tissue engineering, which offers vast room for innovation. However, several challenges hinder growth, including ethical concerns over animal-derived products, regulatory hurdles, and potential disease transmission risks associated with animal-sourced collagen. Companies must ensure stringent safety standards and ethical sourcing to overcome these barriers. The market is moderately competitive, with key players focusing on expanding their product portfolios and improving product quality through innovation. Opportunities exist in niche segments such as personalized medicine, where collagen's unique properties can be tailored for individual patient needs. Overall, the market thrives on continuous innovation in product applications and improvements in regulatory compliance, suggesting a continual evolution and scope for business growth.

KEY MARKET STATISTICS
Base Year [2023] USD 1.37 billion
Estimated Year [2024] USD 1.47 billion
Forecast Year [2030] USD 2.63 billion
CAGR (%) 9.72%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bovine-Based Collagen for Biomedical Applications Market

The Bovine-Based Collagen for Biomedical Applications Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing aging of populations worldwide and increasing prevalence of bone-related diseases
    • Rising investments in biomedical startups to expand their offerings
  • Market Restraints
    • High costs associated with complex and intricate production processes
  • Market Opportunities
    • Growing demand for dental and orthopedic surgeries
    • Ongoing R&D for the development of wound healing and regenerative medicines
  • Market Challenges
    • High risk of transmission of diseases

Porter's Five Forces: A Strategic Tool for Navigating the Bovine-Based Collagen for Biomedical Applications Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bovine-Based Collagen for Biomedical Applications Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bovine-Based Collagen for Biomedical Applications Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bovine-Based Collagen for Biomedical Applications Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bovine-Based Collagen for Biomedical Applications Market

A detailed market share analysis in the Bovine-Based Collagen for Biomedical Applications Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bovine-Based Collagen for Biomedical Applications Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bovine-Based Collagen for Biomedical Applications Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bovine-Based Collagen for Biomedical Applications Market

A strategic analysis of the Bovine-Based Collagen for Biomedical Applications Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bovine-Based Collagen for Biomedical Applications Market, highlighting leading vendors and their innovative profiles. These include Advanced BioMatrix Inc., BBI Solutions, Botiss biomaterials GmbH, Bovine Collagen Products, Collagen Matrix, Inc., Collagen Solutions PLC, Crescent Biotech, Darling Ingredients, Eucare Pharmaceuticals Private Limited, Fisher Scientific International, Inc., Gelita AG, Getinge AB, Integra LifeSciences Holdings Corporation, InterHealth Nutraceuticals Inc., Lapi Gelatine S.p.A., Medtronic PLC, Nippi,incorporated, Nitta Gelatin, Inc., NuCollagen LLC, Shenzhen Ruifuer Electronic Co., Ltd., Symatese, Tessenderlo Group, Titan Biotech Ltd., Viscofan DE GmbH, and Weishardt International.

Market Segmentation & Coverage

This research report categorizes the Bovine-Based Collagen for Biomedical Applications Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Type I and Type III.
  • Based on Application, market is studied across Bone Graft Substitutes, Cartilage Repairs, Collagen-based Scaffolds, Hemostats, Skin Substitutes, and Wound Dressing.
  • Based on End-user, market is studied across Ambulatory Surgical Centers and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing aging of populations worldwide and increasing prevalence of bone-related diseases
      • 5.1.1.2. Rising investments in biomedical startups to expand their offerings
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with complex and intricate production processes
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing demand for dental and orthopedic surgeries
      • 5.1.3.2. Ongoing R&D for the development of wound healing and regenerative medicines
    • 5.1.4. Challenges
      • 5.1.4.1. High risk of transmission of diseases
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bovine-Based Collagen for Biomedical Applications Market, by Type

  • 6.1. Introduction
  • 6.2. Type I
  • 6.3. Type III

7. Bovine-Based Collagen for Biomedical Applications Market, by Application

  • 7.1. Introduction
  • 7.2. Bone Graft Substitutes
  • 7.3. Cartilage Repairs
  • 7.4. Collagen-based Scaffolds
  • 7.5. Hemostats
  • 7.6. Skin Substitutes
  • 7.7. Wound Dressing

8. Bovine-Based Collagen for Biomedical Applications Market, by End-user

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals

9. Americas Bovine-Based Collagen for Biomedical Applications Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Bovine-Based Collagen for Biomedical Applications Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Bovine-Based Collagen for Biomedical Applications Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advanced BioMatrix Inc.
  • 2. BBI Solutions
  • 3. Botiss biomaterials GmbH
  • 4. Bovine Collagen Products
  • 5. Collagen Matrix, Inc.
  • 6. Collagen Solutions PLC
  • 7. Crescent Biotech
  • 8. Darling Ingredients
  • 9. Eucare Pharmaceuticals Private Limited
  • 10. Fisher Scientific International, Inc.
  • 11. Gelita AG
  • 12. Getinge AB
  • 13. Integra LifeSciences Holdings Corporation
  • 14. InterHealth Nutraceuticals Inc.
  • 15. Lapi Gelatine S.p.A.
  • 16. Medtronic PLC
  • 17. Nippi,incorporated
  • 18. Nitta Gelatin, Inc.
  • 19. NuCollagen LLC
  • 20. Shenzhen Ruifuer Electronic Co., Ltd.
  • 21. Symatese
  • 22. Tessenderlo Group
  • 23. Titan Biotech Ltd.
  • 24. Viscofan DE GmbH
  • 25. Weishardt International
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦